MAQAF (Atlas Arteria) EPS without NRI: $0.12 (TTM As of Dec. 2025)


MAQAF Atlas Arteria Ltd MAQAF
75 GF Score
Price $3.58
GF Value $4.03
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Atlas Arteria EPS without NRI?

Atlas Arteria MAQAF 75 EPS without NRI is $0.12 as of Dec. 2025. GuruFocus rates MAQAF with a GF Score™ of 75/100 and a GF Value™ of $4.03 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 1,333 Construction companies, Atlas Arteria ranks worse than 74.79% on this metric.

Atlas Arteria's earnings per share without non-recurring items for the six months ended in Dec. 2025 was $0.09. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was $0.12.

During the past 12 months, Atlas Arteria's average earnings per share (NRI) Growth Rate was -22.80% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was -10.10% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was 17.50% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was -2.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Atlas Arteria's EPS without NRI or its related term are showing as below:

MAQAF' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -55.5   Med: 16.65   Max: 70.7
Current: -10.1

During the past 13 years, Atlas Arteria's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 70.70% per year. The lowest was -55.50% per year. And the median was 16.65% per year.

MAQAF's 3-Year EPS without NRI Growth Rate is ranked worse than
74.79% of 1333 companies
in the Construction industry
Industry Median: 9.1 vs MAQAF: -10.10

Atlas Arteria's EPS (Diluted) for the six months ended in Dec. 2025 was $0.09. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $0.12.

Atlas Arteria's EPS (Basic) for the six months ended in Dec. 2025 was $0.09. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was $0.12.


Atlas Arteria  (OTCPK:MAQAF) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Atlas Arteria EPS without NRI Related Terms


Atlas Arteria EPS without NRI Historical Data

* Premium members only.

The historical data trend for Atlas Arteria's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Atlas Arteria EPS without NRI Chart

Atlas Arteria Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.11 0.17 0.15 0.15 0.12

Atlas Arteria Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.09 0.05 0.10 0.03 0.09

Atlas Arteria EPS without NRI Competitor Comparison

For the Infrastructure Operations subindustry, Atlas Arteria's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Atlas Arteria PE Ratio without NRI vs Construction Industry

For the Construction industry and Industrials sector, Atlas Arteria's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Atlas Arteria's PE Ratio without NRI falls into.


MAQAF
75GF Score
Atlas Arteria Ltd MAQAF
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Atlas Arteria EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of $0.12 mean?
Atlas Arteria (MAQAF) has a EPS without NRI of $0.12 as of Dec. 2025. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Atlas Arteria and its competitors. According to the industry distribution chart, Atlas Arteria ranks #997 out of 1333 companies in the Construction industry, placing it in the top 74.8%.
Is Atlas Arteria's EPS without NRI too high?
Atlas Arteria's current EPS without NRI is $0.12. The Construction industry median EPS without NRI is 9.10. Atlas Arteria's value of $0.12 is 98.7% below this industry median. Based on the distribution chart, Atlas Arteria ranks #997 out of 1333 companies in the Construction industry, which is below the industry midpoint. Overall, Atlas Arteria has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Atlas Arteria's EPS without NRI compare to competitors?
According to the Construction industry distribution chart, Atlas Arteria ranks #997 out of 1333 companies for EPS without NRI. This places Atlas Arteria in the lower half of its industry. The industry median EPS without NRI is 9.10. Atlas Arteria's value of $0.12 is 98.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Construction company?
The median EPS without NRI among Construction companies is 9.10, based on 1,333 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Atlas Arteria's current EPS without NRI of $0.12 is 98.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Atlas Arteria and its competitors. For the Construction industry, the median EPS without NRI is 9.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Atlas Arteria's current EPS without NRI is $0.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Atlas Arteria stock overvalued right now?
Based on GuruFocus' analysis, Atlas Arteria (MAQAF) is currently considered Modestly Undervalued. The stock's GF Value™ is $4.03, compared to a current price of $3.58 — trading 11.3% below its estimated fair value. The current EPS without NRI is $0.12 and 98.7% below the Construction industry median of 9.10. Atlas Arteria's overall GF Score™ is 75/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Atlas Arteria (MAQAF), the current EPS without NRI is $0.12 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Atlas Arteria (MAQAF) Overvalued in 2026?

Based on GuruFocus' analysis, Atlas Arteria stock appears to be undervalued. The current stock price of $3.58 is trading 11.3% below its estimated GF Value™ of $4.03. GuruFocus considers Atlas Arteria to be Modestly Undervalued.

Key valuation signals for MAQAF:

  • EPS without NRI: $0.12
  • GF Value™: $4.03 vs. price of $3.58 (11.3% below fair value)
  • GF Score™: 75/100 with 6 warning signs
  • Industry Position: 98.7% below the Construction median (#997 of 1333)

No single metric tells the full story. See the MAQAF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Atlas Arteria Business Description

Other Exchanges M82:GermanyALX:Australia
Address 180 Flinders Street, Level 1, Melbourne, VIC, AUS, 3000
Atlas Arteria is a global toll-road investor created out of the reorganization of Macquarie Infrastructure Group in 2010. The firm's main asset is a 30.82% stake in APRR. APRR owns concessions to toll more than 2,300 kilometers of motorways in eastern France, most ending by late 2035. The firm also wholly owns the Dulles Greenway and 66.67% of the Chicago Skyway, both in the US.
75GF Score

Get the complete analysis for MAQAF

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.58
Price
$4.03
GF Value